Gone to Texas Room

A Case-Based Discussion on Recognition and Treatment of Primary Humoral Immunodeficiency Disease (PIDD)                       

Raffi Tachdjian, MD, MPH Associate Professor of Pediatrics and Medicine

University of California Los Angeles School of Medicine

Ranger Room 

Long-term evidence in Hereditary Angioedema (HAE): Differential Diagnoses and Effective Attack Prevention

William R. Lumry, M.D., P.A. Allergy & Asthma Specialist of Dallas, Texas

Mina Room

Optimizing Ig Treatment for People Living with Primary Immunodeficiency

Lukena Karkhanis, MD Medical Director Allergy SA, San Antonio, TX

Gone to Texas Room

Elevating Care in Chronic Rhinosinusitis with Nasal Polyps (CRSwNP): A Path to Sustained Control     

Charles Lane, MD Allergy Partners of Lynchburg

Ranger Room

Starting at the top: A different approach to severe asthma and CRSwNP

Dr. Ekta Perera, Dr. Joe Diaz

Gone to Texas Room

The First and Only RNA-targeted Therapy for Hereditary Angioedema Prophylaxis

William R. Lumry, M.D., P.A. Allergy & Asthma Specialist of Dallas, Texas

 Ranger Room

An Opportunity to Address Outcomes in Severe Eosinophilic Asthma

Dr. Anil Nanda, Dr. Neha Reshamwala

More Information to Come

Gone to Texas Room

Explore EBGLYSS: See how EBGLYSS® can leave a lasting impression

Priya Bansal MD, Asthma & Allergy Wellness Center, St. Charles, IL

Ranger Room

A Clinical Look at ORLADEYO: From Results to Real-World Practice

Jeffrey Rumbyrt, MD Boulder Valley Asthma and Allergy Clinics Lakewood, CO

Gone to Texas Room

A Biologic You Know, Now Approved In Chronic Spontaneous Urticaria (CSU)

Ujwala Kaza, MD ENT and Allergy Associates, New York, NY

Ranger Room

Explore the potential of RHAPSIDO

Lukena Karkhanis, MD Medical Director Allergy SA, San Antonio, TX

Gone to Texas Room

Clinical Evidence in Severe Asthma: A New Biologic Option for Patients with an Eosinophilic Phenotype

Maeve Edel O’Connor, MD, FACAAI, FAAAAI, FACP

Ranger Room

Advances in the Understanding and Management of HAE

John Anderson, MD, Birmingham, Alabama

Mina Room

Evidence Expedition: An Interactive Journey Through Clinical Data For AIRSUPRA? (albuterol 90mcg/budesonide 80mcg)

Dr. Amy Wagelie-Steffen, Allergy & Asthma Associates, Tucson, Arizona

Dr. Justin Griewe, Advanced Allergy Services, Cincinnati, Ohio

Gone to Texas Room

Personalizing Ig Therapy in Patients With PI

Araceli Elizalde, MD Allergy and Asthma Texas Health

Erin Pratt, MD Acadiana Allergy, Asthma, and Immunology Center

Gone to Texas Room

An in-depth discussion on EKTERLY® (sebetralstat), the first and only oral on-demand treatment that helps your patients stop hereditary angioedema (HAE) attacks fast.

William R. Lumry, M.D., P.A. Allergy & Asthma Specialist of Dallas, Texas

In 2024, TAAIS had 57 residents in internal medicine and pediatrics from training programs across the state of Texas attend to learn more about the specialty of allergy and immunology.  Leaders in the A/I field gave short lectures about immunologic diseases, allergic diseases, asthma, anaphylaxis, food allergies and drug allergies.  A networking luncheon followed and allowed the residents to ask questions of the speakers and gain more information about A/I fellowships and careers.  

In 2025, the Conference will again be held at the beautiful Lakeway Resort on Lake Travis in Austin, Texas where residents can enjoy the facilities and the lake at the conclusion of the Conference. 

28th Annual Conference Registration

Registration is by invitation only.  Invitations will go out in May/June to the internal medicine and pediatrics training program directors throughout the State of Texas and training program directors will nominate their residents to attend the Conference.